 |
|
Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease
Hee Young Ju (Ju HY), Hyoung Jin Kang (Kang HJ), Che Ry Hong (Hong CR), Ji Won Lee (Lee JW), Hyery Kim (Kim H), Sang Hoon Song (Song SH), Kyung-Sang Yu (Yu KS), In-Jin Jang (Jang IJ), June Dong Park (Park JD), Kyung Duk Park (Park KD), Hee Young Shin (Shin HY), Joong-Gon Kim (Kim JG), Hyo Seop Ahn (Ahn HS)
Clin Exp Pediatr. 2016;59(Suppl 1):S57-S59. Published online 2016 Nov 30 DOI: https://doi.org/10.3345/kjp.2016.59.11.S57
|
|
Citations to this article as recorded by
 A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review
Mohammad Vaezi, Maryam Souri, Seyed Amin Setarehdan, Amir Ali Hamidieh, Mohammad Reza Fazlollahi, Zahra Pourpak, Mohsen Badalzadeh, Shaghayegh Tajik, Seyed Alireza Mahdaviani, Kamran Alimoghaddam, Ardeshir Ghavamzadeh
Annals of Hematology.2022; 101(4): 869. CrossRef Systematic review of literature and analysis of big data from the National Health Insurance System on primary immunodeficiencies in Korea
Sohee Son, Ji-Man Kang, Younsoo Hahn, Kangmo Ahn, Yae-Jean Kim
Clinical and Experimental Pediatrics.2021; 64(4): 141. CrossRef Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)
Dirk Roos, Karin van Leeuwen, Amy P. Hsu, Debra Long Priel, Amber Begtrup, Rhonda Brandon, Marie José Stasia, Faris Ghalib Bakri, Nezihe Köker, M. Yavuz Köker, Manisha Madkaika, Martin de Boer, Maria Bravo Garcia-Morato, Juan Luis Valdivieso Shephard, Joa
Blood Cells, Molecules, and Diseases.2021; 90: 102587. CrossRef
|